Global Biologics and Biosimilars Market Status and Outlook 2018-2025

July 2018 | 210 pages | ID: G066F9156EDEN
99Strategy

Abstracts

REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application / End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies

• Roche
• Amgen
• AbbVie
• Sanofi-Aventis
• Johnson & Johnson
• Pfizer
• Novo Nordisk
• Eli Lilly
• Novartis
• Merck
• 3sbio
• Changchun High Tech
• CP Guojian
• Biotech
• Gelgen
• Innovent
• Dong Bao
• Ganlee
• United Laboratories

Market by Type

• Antibody
• Hormone
• Growth Factors
• Others

Market by Application

• Tumor
• Diabetes
• Cardiovascular
• Hemophilia
• Others

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Biologics and Biosimilars Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Antibody
  3.1.2 Hormone
  3.1.3 Growth Factors
  3.1.4 Others
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Tumor
  4.1.2 Diabetes
  4.1.3 Cardiovascular
  4.1.4 Hemophilia
  4.1.5 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sultan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Antibody Production by Region
    6.1.1.2 Hormone Production by Region
    6.1.1.3 Growth Factors Production by Region
    6.1.1.4 Others Production by Region
  6.1.2 Production by Application
    6.1.2.1 Tumor Production by Region
    6.1.2.2 Diabetes Production by Region
    6.1.2.3 Cardiovascular Production by Region
    6.1.2.4 Hemophilia Production by Region
    6.1.2.5 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Antibody Demand by Region
    6.2.1.2 Hormone Demand by Region
    6.2.1.3 Growth Factors Demand by Region
    6.2.1.4 Others Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Tumor Demand by Region
    6.2.2.2 Diabetes Demand by Region
    6.2.2.3 Cardiovascular Demand by Region
    6.2.2.4 Hemophilia Demand by Region
    6.2.2.5 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Roche
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Amgen
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 AbbVie
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Sanofi-Aventis
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Johnson & Johnson
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Pfizer
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Novo Nordisk
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Eli Lilly
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 Novartis
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation
8.10 Merck
  8.10.1 Company Information
  8.10.2 Products & Services
  8.10.3 Business Operation
8.11 3sbio
8.12 Changchun High Tech
8.13 CP Guojian
8.14 Biotech
8.15 Gelgen
8.16 Innovent
8.17 Dong Bao
8.18 Ganlee
8.19 United Laboratories

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Biologics and Biosimilars Industry Dynamics & Regulations List
Table Global Biologics and Biosimilars Sales Revenue, Cost and Margin, 2015-2018E
Table Global Biologics and Biosimilars Market Status by Type 2015-2018E, in USD Million
Table Global Biologics and Biosimilars Market Status by Application 2015-2018E, in USD Million
Table Global Biologics and Biosimilars Market by Region 2015-2018E, in USD Million
Table Global Biologics and Biosimilars Market Share by Region in 2018, in USD Million
Table Antibody Production Value by Region 2015-2018E, in USD Million
Table Antibody Production Volume by Region 2015-2018E, in Volume
Table Hormone Production Value by Region 2015-2018E, in USD Million
Table Hormone Production Volume by Region 2015-2018E, in Volume
Table Growth Factors Production Value by Region 2015-2018E, in USD Million
Table Growth Factors Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Tumor Production Value by Region 2015-2018E, in USD Million
Table Tumor Production Volume by Region 2015-2018E, in Volume
Table Diabetes Production Value by Region 2015-2018E, in USD Million
Table Diabetes Production Volume by Region 2015-2018E, in Volume
Table Cardiovascular Production Value by Region 2015-2018E, in USD Million
Table Cardiovascular Production Volume by Region 2015-2018E, in Volume
Table Hemophilia Production Value by Region 2015-2018E, in USD Million
Table Hemophilia Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Antibody Market Size by Region 2015-2018E, in USD Million
Table Antibody Market Size by Region 2015-2018E, in Volume
Table Hormone Market Size by Region 2015-2018E, in USD Million
Table Hormone Market Size by Region 2015-2018E, in Volume
Table Growth Factors Market Size by Region 2015-2018E, in USD Million
Table Growth Factors Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table Tumor Market Size by Region 2015-2018E, in USD Million
Table Tumor Market Size by Region 2015-2018E, in Volume
Table Diabetes Market Size by Region 2015-2018E, in USD Million
Table Diabetes Market Size by Region 2015-2018E, in Volume
Table Cardiovascular Market Size by Region 2015-2018E, in USD Million
Table Cardiovascular Market Size by Region 2015-2018E, in Volume
Table Hemophilia Market Size by Region 2015-2018E, in USD Million
Table Hemophilia Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalBiologics and Biosimilars Forecast by Type 2019F-2025F, in USD Million
Table Biologics and Biosimilars Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Biologics and Biosimilars Market Forecast by Region 2019F-2025F, in USD Million
Table Roche Information
Table Biologics and Biosimilars Sales, Cost, Margin of Roche
Table Amgen Information
Table Biologics and Biosimilars Sales, Cost, Margin of Amgen
Table AbbVie Information
Table Biologics and Biosimilars Sales, Cost, Margin of AbbVie
Table Sanofi-Aventis Information
Table Biologics and Biosimilars Sales, Cost, Margin of Sanofi-Aventis
Table Johnson & Johnson Information
Table Biologics and Biosimilars Sales, Cost, Margin of Johnson & Johnson
Table Pfizer Information
Table Biologics and Biosimilars Sales, Cost, Margin of Pfizer
Table Novo Nordisk Information
Table Biologics and Biosimilars Sales, Cost, Margin of Novo Nordisk
Table Eli Lilly Information
Table Biologics and Biosimilars Sales, Cost, Margin of Eli Lilly
Table Novartis Information
Table Biologics and Biosimilars Sales, Cost, Margin of Novartis
Table Merck Information
Table Biologics and Biosimilars Sales, Cost, Margin of Merck
Table 3sbio Information
Table Biologics and Biosimilars Sales, Cost, Margin of 3sbio
Table Changchun High Tech Information
Table Biologics and Biosimilars Sales, Cost, Margin of Changchun High Tech
Table CP Guojian Information
Table Biologics and Biosimilars Sales, Cost, Margin of CP Guojian
Table Biotech Information
Table Biologics and Biosimilars Sales, Cost, Margin of Biotech
Table Gelgen Information
Table Biologics and Biosimilars Sales, Cost, Margin of Gelgen
Table Innovent Information
Table Biologics and Biosimilars Sales, Cost, Margin of Innovent
Table Dong Bao Information
Table Biologics and Biosimilars Sales, Cost, Margin of Dong Bao
Table Ganlee Information
Table Biologics and Biosimilars Sales, Cost, Margin of Ganlee
Table United Laboratories Information
Table Biologics and Biosimilars Sales, Cost, Margin of United Laboratories
Table Global Biologics and Biosimilars Sales Revenue by Company 2015-2017, in USD Million

List Of Figures

LIST OF FIGURES

Figure Biologics and Biosimilars Picture
Figure Biologics and Biosimilars Industry Chain Diagram
Figure Global Biologics and Biosimilars Sales Revenue 2015-2018E, in USD Million
Figure North America Biologics and Biosimilars Market Size and Growth 2015-2018E, in USD Million
Figure Europe Biologics and Biosimilars Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Biologics and Biosimilars Market Size and Growth 2015-2018E, in USD Million
Figure South America Biologics and Biosimilars Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Biologics and Biosimilars Market Size and Growth 2015-2018E, in USD Million
Figure Africa Biologics and Biosimilars Market Size and Growth 2015-2018E, in USD Million
Figure Global Biologics and Biosimilars Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Biologics and Biosimilars Gross Margin Forecast 2019F-2025F
Figure Global Biologics and Biosimilars Sales Revenue by Company in 2018, in USD Million
Figure Global Biologics and Biosimilars Gross Margin by Company in 2018